Is JetBlue The Best Airline Stock?
Following a general trend of improvement among airline stocks, shares…
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/28/2026 | Q1 | $16.7M | -- | -- | -$0.83 | -- |
| 01/28/2026 | Q4 | $13.4M | -- | -- | -$0.92 | -- |
| 10/09/2025 | Q3 | $16.1M | $7.9M | -$1.03 | -$0.85 | -$0.18 |
| 07/10/2025 | Q2 | $17.5M | $44.1M | -$0.52 | -$0.74 | $0.23 |
| 04/08/2025 | Q1 | $13M | $18.5M | -$0.67 | -$0.76 | $0.09 |
| 01/28/2025 | Q4 | $12.9M | $13.3M | -$0.75 | -$0.67 | -$0.08 |
| 10/11/2024 | Q3 | $12.3M | $12.6M | -$0.67 | -$0.68 | $0.01 |
| 07/11/2024 | Q2 | $21.8M | $12.1M | -$0.71 | -$0.63 | -$0.08 |
| 04/10/2024 | Q1 | $17.1M | $16.6M | -$0.76 | -$0.79 | $0.03 |
| 02/15/2024 | Q4 | $34.1M | $15.2M | -$0.77 | -$0.50 | -$0.27 |
| 10/12/2023 | Q3 | -- | $18.5M | -$0.68 | -- | -- |
| 07/13/2023 | Q2 | -- | $30.7M | -$0.45 | -- | -- |
| 04/13/2023 | Q1 | -- | $12.7M | -$0.75 | -- | -- |
| 02/09/2023 | Q4 | -- | $6.8M | -$0.87 | -- | -- |
| 10/06/2022 | Q3 | -- | $10.8M | -$0.90 | -- | -- |
| 07/07/2022 | Q2 | -- | $11.4M | -$1.01 | -- | -- |
| 04/08/2022 | Q1 | -- | $9.6M | -$0.95 | -- | -- |
| 01/27/2022 | Q4 | -- | $7.4M | -$0.85 | -- | -- |
| 10/14/2021 | Q3 | -- | $10.3M | -$0.65 | -- | -- |
| 07/13/2021 | Q2 | -- | $7.1M | -$0.60 | -- | -- |
| 04/13/2021 | Q1 | -- | $5M | -$0.63 | -- | -- |
| 02/16/2021 | Q4 | -- | $6.7M | -$0.51 | -- | -- |
| 10/14/2020 | Q3 | -- | $4.1M | -$1.77 | -- | -- |
| 05/31/2020 | Q2 | -- | $4.2M | $0.20 | -- | -- |
| 02/29/2020 | Q1 | -- | $2.9M | -$0.96 | -- | -- |
| 11/30/2019 | Q4 | -- | $1.9M | -$0.35 | -- | -- |
| 08/31/2019 | Q3 | -- | $10.6M | -$0.22 | -- | -- |
| 05/31/2019 | Q2 | -- | $9.4M | -$0.08 | -- | -- |
| 02/28/2019 | Q1 | -- | $9.2M | -$0.21 | -- | -- |
Nurix Therapeutics, Inc. reported $7.9M worth of top line sales in its most recent quarter.
Nurix Therapeutics, Inc. announced earnings per share of -$1.03 which represents a miss of analyst forecast a -$0.85 per share.
Nurix Therapeutics, Inc. reported $2.9M that represents $0.03 per share over the last quarter.
Nurix Therapeutics, Inc.'s earnings are forecast to decrease from -$2.88 per share to -$3.11 per share next year representing a decrease of -7.77%.
Nurix Therapeutics, Inc.'s next earnings date is January 28, 2026.
Signup to receive the latest stock alerts
Following a general trend of improvement among airline stocks, shares…
Following a bidding war, Netflix (NASDAQ:NFLX) has announced its intention…
Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…
Market Cap: $4.5T
P/E Ratio: 63x
Market Cap: $4.1T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 40x
Photronics, Inc. [PLAB] is up 45.35% over the past day.
Olema Pharmaceuticals, Inc. [OLMA] is up 15.35% over the past day.
Telesat Corp. [TSAT] is up 3.07% over the past day.